Latest News and Press Releases

Intratumoral injections of INT230-6 were well tolerated with no drug-related serious adverse events or dose-limiting toxicityIncreases in circulating CD8 and CD4 T-cells and evidence of abscopal...

NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...

ZEJULA is the first and only PARP inhibitor approved in Hong Kong for the maintenance treatment of platinum-sensitive relapsed ovarian cancer irrespective of BRCA mutation status Zai Lab expects to...

WELLINGTON, Fla., Oct. 22, 2018 (GLOBE NEWSWIRE) -- KLX Energy Services Holdings, Inc. (“KLX Energy Services” or the “Company”) (NASDAQ: KLXE), announced today its intention to commence a private...

~ As Previously Reported, SONICS Met its Primary Endpoint With 30 Percent of the ITT Patient Population Reaching & Maintaining Mean Urinary Free Cortisol (mUFC) Normalization Following Six Months...

TORONTO, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Petrolympic Ltd. (the "Company") (TSX.V: PCQ – OTCQB:PCQRF) is pleased to announce the closing of a non-brokered private placement (the "Offering"),...

BEVERLY, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide a development update on...

Net income of $18.0 million, or $.46 per diluted share, in the third quarter of 2018Return on assets of 1.43% and return on equity of 10.76% Organic and PNCI loan growth of $56 millionMerger-related...

NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...

WELLINGTON, Fla., Oct. 22, 2018 (GLOBE NEWSWIRE) -- KLX Energy Services Holdings, Inc. (“KLX Energy Services” or the “Company”) (NASDAQ: KLXE), a leading U.S. onshore provider of mission critical...